Beringea’s Investment In OurPath


Marriott Harrison advised Beringea on its investment in OurPath, as part of the company’s $10 million Series A fundraising.

OurPath, rebranded as Second Nature, aims to tackle the issues of diabetes and obesity, and the health tech start up is the first ‘lifestyle change program’ to be commissioned by the NHS for diabetes management.

Beringea is an international investor in high growth US & UK businesses.

The Marriott Harrison team was led by corporate partner David Strong (Picture) and included Graham Halliday, Kerry Corrigan, Chris Mooney, Ed Belam, Alex Lee and Sofia Gottgens.

Involved fees earner: Ed Belam – Marriott Harrison; Kerry Corrigan – Marriott Harrison; Graham Halliday – Marriott Harrison; Alex Lee – Marriott Harrison; Chris Mooney – Marriott Harrison; David Strong – Marriott Harrison;

Law Firms: Marriott Harrison;

Clients: Beringea LLC;

Print Friendly, PDF & Email